These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 38184005)
41. The risk of mortality and severe illness in patients infected with the omicron variant relative to delta variant of SARS-CoV-2: a systematic review and meta-analysis. Kow CS; Ramachandram DS; Hasan SS Ir J Med Sci; 2023 Dec; 192(6):2897-2904. PubMed ID: 36754948 [TBL] [Abstract][Full Text] [Related]
42. Emerging SARS-CoV-2 variants: impact on vaccine efficacy and neutralizing antibodies. Sharun K; Tiwari R; Dhama K; Emran TB; Rabaan AA; Al Mutair A Hum Vaccin Immunother; 2021 Oct; 17(10):3491-3494. PubMed ID: 34161189 [TBL] [Abstract][Full Text] [Related]
43. Nebulized delivery of a broadly neutralizing SARS-CoV-2 RBD-specific nanobody prevents clinical, virological, and pathological disease in a Syrian hamster model of COVID-19. Esparza TJ; Chen Y; Martin NP; Bielefeldt-Ohmann H; Bowen RA; Tolbert WD; Pazgier M; Brody DL MAbs; 2022; 14(1):2047144. PubMed ID: 35289719 [TBL] [Abstract][Full Text] [Related]
44. SARS-CoV-2 exposure in Malawian blood donors: an analysis of seroprevalence and variant dynamics between January 2020 and July 2021. Mandolo J; Msefula J; Henrion MYR; Brown C; Moyo B; Samon A; Moyo-Gwete T; Makhado Z; Ayres F; Motlou T; Mzindle N; Kalata N; Muula AS; Kwatra G; Nsamala N; Likaka A; Mfune T; Moore PL; Mbaya B; French N; Heyderman RS; Swarthout T; Jambo KC BMC Med; 2021 Nov; 19(1):303. PubMed ID: 34794434 [TBL] [Abstract][Full Text] [Related]
45. In-hospital adverse outcomes and risk factors among chronic kidney disease patients infected with the omicron variant of SARS-CoV-2: a single-center retrospective study. Guo Y; Guo Y; Ying H; Yu W; Chen S; Zhang Y; Zhang S; Lin Y; Sun F; Zhang Y; Yu J; Ma K; Qin L; Long F; Zhu H; Mao R; Xue J; Zhang J BMC Infect Dis; 2023 Oct; 23(1):698. PubMed ID: 37853317 [TBL] [Abstract][Full Text] [Related]
46. Clinical and virological course of patients with coronavirus disease 2019 in Jiangsu province, China: a retrospective, multi-center cohort study. Huang R; Zhu L; Xue L; Yan X; Wang J; Huang S; Zhang B; Xu T; Ji F; Li C; Ming F; Zhao Y; Li Y; Cheng J; Wang Y; Shao H; Hong S; Chen K; Zhao XA; Sang D; Zou L; Zhao H; Guan X; Chen X; Xu B; Xia J; Chen Y; Yan X; Wei J; Liu J; Liu L; Zhu C; Wu C Virol J; 2021 Jul; 18(1):147. PubMed ID: 34261488 [TBL] [Abstract][Full Text] [Related]
47. Infection and Transmission of SARS-CoV-2 B.1.617.2 Lineage (Delta Variant) among Fully Vaccinated Individuals. Caserta LC; Martins M; Cronk B; Anderson R; Eldridge H; Gallow D; Kruppa F; Plocharczyk E; Diel DG Microbiol Spectr; 2022 Oct; 10(5):e0056322. PubMed ID: 36165775 [TBL] [Abstract][Full Text] [Related]
48. Hepatic dysfunctions in COVID-19 patients infected by the omicron variant of SARS-CoV-2. Zhang J; Zhao D; Hu J; Huang X; Gu Q; Tao Z Front Public Health; 2022; 10():1049006. PubMed ID: 36466505 [TBL] [Abstract][Full Text] [Related]
49. Early detection of P.1 variant of SARS-CoV-2 in a cluster of cases in Salvador, Brazil. de Siqueira IC; Camelier AA; Maciel EAP; Nonaka CKV; Neves MCLC; Macêdo YSF; de Sousa KAF; Araujo VC; Paste AA; Souza BSF; Gräf T Int J Infect Dis; 2021 Jul; 108():252-255. PubMed ID: 33989776 [TBL] [Abstract][Full Text] [Related]
50. An outbreak caused by the SARS-CoV-2 Delta (B.1.617.2) variant in a care home after partial vaccination with a single dose of the COVID-19 vaccine Vaxzevria, London, England, April 2021. Williams SV; Vusirikala A; Ladhani SN; Fernandez Ruiz De Olano E; Iyanger N; Aiano F; Stoker K; Gopal Rao G; John L; Patel B; Andrews N; Dabrera G; Ramsay M; Brown KE; Lopez Bernal J; Saliba V Euro Surveill; 2021 Jul; 26(27):. PubMed ID: 34240699 [TBL] [Abstract][Full Text] [Related]
51. SARS-CoV-2 Placentitis Associated With B.1.617.2 (Delta) Variant and Fetal Distress or Demise. Shook LL; Brigida S; Regan J; Flynn JP; Mohammadi A; Etemad B; Siegel MR; Clapp MA; Li JZ; Roberts DJ; Edlow AG J Infect Dis; 2022 Mar; 225(5):754-758. PubMed ID: 35024844 [TBL] [Abstract][Full Text] [Related]
52. Omicron SARS-CoV-2 new variant: global prevalence and biological and clinical characteristics. Meo SA; Meo AS; Al-Jassir FF; Klonoff DC Eur Rev Med Pharmacol Sci; 2021 Dec; 25(24):8012-8018. PubMed ID: 34982465 [TBL] [Abstract][Full Text] [Related]
53. Comparison of the Performance of the PanBio COVID-19 Antigen Test in SARS-CoV-2 B.1.1.7 (Alpha) Variants versus non-B.1.1.7 Variants. van Ogtrop ML; van de Laar TJW; Eggink D; Vanhommerig JW; van der Reijden WA Microbiol Spectr; 2021 Dec; 9(3):e0088421. PubMed ID: 34817226 [TBL] [Abstract][Full Text] [Related]
54. Clinical and Pulmonary CT Characteristics of Patients Infected With the SARS-CoV-2 Omicron Variant Compared With Those of Patients Infected With the Alpha Viral Strain. Yang N; Wang C; Huang J; Dong J; Ye J; Fu Y; Huang J; Xu D; Cao G; Qian G Front Public Health; 2022; 10():931480. PubMed ID: 35903393 [TBL] [Abstract][Full Text] [Related]
55. Immunological and Pathological Peculiarity of Severe Acute Respiratory Syndrome Coronavirus 2 Beta Variant. Lee S; Yoon GY; Lee SJ; Kwon YC; Moon HW; Kim YJ; Kim H; Lee W; Jeong GU; Kim C; Kim KD; Kim SJ; Ahn DG Microbiol Spectr; 2022 Oct; 10(5):e0237122. PubMed ID: 36005818 [TBL] [Abstract][Full Text] [Related]